Life Sciences Collagen Scaffold Solutions sector
Strategic acquirers, private equity (buyout funds and growth funds) firms, and valuation benchmarks for Life Sciences Collagen Scaffold Solutions
1.1 - About Life Sciences Collagen Scaffold Solutions sector
Companies in Life Sciences Collagen Scaffold Solutions design and manufacture collagen-based 3D matrices for tissue engineering, regenerative medicine, and advanced cell culture. They supply research- and medical device–grade biomaterials that mimic extracellular matrix, enabling cell adhesion, proliferation, and controlled remodeling. Strategic buyers in collagen scaffolds prioritize scalable, regulatory-ready materials that accelerate preclinical studies, support implant and wound dressing development, and standardize in vitro models with consistent mechanical and biochemical properties.
Vendors typically offer GMP-compliant collagen scaffold manufacturing, customizable porosity and stiffness tuning, decellularized ECM and hydrogel formulations, sterile pre-cut sheets and 3D constructs, growth factor and peptide functionalization, and integration with 3D bioprinting via bioinks. They provide mechanical and biochemical characterization, endotoxin testing, and batch traceability, along with design support for bone, cartilage, dermal, and dental indications, as well as organoid and cell culture models used in discovery and translational research.
Primary customers include regenerative medicine startups and medtech device manufacturers, academic and translational research labs, and biopharma R&D groups pursuing cell and gene therapies. These solutions enable faster prototype iteration, improved cell viability and scaffold integration, reproducible in vitro testing, and clearer regulatory pathways through ISO 13485 documentation and validated QC. Outcomes include reduced time to clinic, higher success rates in preclinical models, and scalable manufacturing readiness.
2. Buyers in the Life Sciences Collagen Scaffold Solutions sector
2.1 Top strategic acquirers of Life Sciences Collagen Scaffold Solutions companies
Humacyte
- Description: Provider of regenerative medicine solutions developing and manufacturing universally implantable, lab-grown acellular tissue engineered vessels (ATEV) and other bioengineered tissues that remodel with patients’ own cells to treat extremity arterial trauma, enable arteriovenous access for hemodialysis, address peripheral arterial disease and lay groundwork for future organ replacement applications.
- Key Products:
- Symvess (Acellular Tissue Engineered Vessel): FDA-approved, universally implantable bioengineered human vessel for extremity arterial trauma, provides off-the-shelf conduit when autologous vein grafts are infeasible and remodels with patient cells
- ATEV for Arteriovenous (AV) Access: Lab-grown vessel in clinical trials to create durable, infection-resistant access sites for hemodialysis patients, aiming to improve longevity over synthetic grafts
- ATEV for Peripheral Arterial Disease: Investigational vessel intended to restore blood flow in diseased peripheral arteries, offering biologically compatible alternative to synthetic bypass grafts
- Pipeline Tissue & Organ Applications: Preclinical programs exploring ATEV technology for coronary artery bypass, pediatric heart surgery and type-1 diabetes treatments, extending platform to multiple novel cell and tissue uses.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
2.2 - Strategic buyer groups for Life Sciences Collagen Scaffold Solutions sector
M&A buyer group 1: Regenerative Medicine
Orthofix
- Type: N/A
- Employees: ●●●●●
- Description: Provider of comprehensive orthopedic solutions and limb reconstruction products supporting adult and pediatric patients worldwide, offering hardware, enabling digital services, biologics engineered for bony fusion, and non-invasive fracture-healing devices that enhance natural bone growth.
- Key Products:
- Spinal Solutions: Advanced interbody and fixation implants that restore alignment, improve disc height, decompress nerves and correct instabilities across deformity, minimally invasive, trauma and tumor spine procedures
- Orthopedic Solutions: Comprehensive limb reconstruction hardware and enabling digital tools supporting clinicians throughout patient pathway for challenging adult and pediatric orthopedic conditions worldwide
- Bone Growth Therapy Devices: Non-surgical PEMF or LIPUS stimulators delivering therapeutic energy to promote spinal fusion and heal nonunion fractures
- number one prescribed bone growth stimulators in the U.S
- 7D FLASH Navigation System: Camera-based, machine-vision surgical navigation platform for spine and cranial procedures, providing fast, precise image-guided workflows that overcome limitations of legacy systems.
Buyer group 2: ████████ ████████
●● companiesBuyer group 3: ████████ ████████
●● companies3. Investors and private equity firms in Life Sciences Collagen Scaffold Solutions sector
3.1 - Buyout funds in the Life Sciences Collagen Scaffold Solutions sector
2.2 - Strategic buyer groups for Life Sciences Collagen Scaffold Solutions sector
4 - Top valuation comps for Life Sciences Collagen Scaffold Solutions companies
4.2 - Public trading comparable groups for Life Sciences Collagen Scaffold Solutions sector
Valuation benchmark group 1: Pharma Packaging and Medical Consumables Companies
Thermo Fisher Scientific
- Enterprise value: $●●●m
- Market Cap: $●●●m
- EV/Revenue: ●.●x
- EV/EBITDA: ●●.●x
- Description: Provider of analytical instruments, life sciences solutions, specialty diagnostics, and laboratory, pharmaceutical and biotechnology services, enabling advancements in research, diagnostics, and industrial applications.
- Key Products:
- Analytical instruments: Tools for precise measurement and analysis in various fields
- Life sciences solutions: Reagents, lab equipment, and consumables for life sciences research
- Specialty diagnostics: Diagnostic equipment and kits for clinical and industrial use
- Laboratory services: Comprehensive support services for lab operations
- Pharmaceutical services: Solutions for drug development and manufacturing.